These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25879325)

  • 21. Effects of amino acid and trace element supplementation on pneumocandin production by Glarea lozoyensis: impact on titer, analogue levels, and the identification of new analogues of pneumocandin B(0).
    Petersen LA; Hughes DL; Hughes R; DiMichele L; Salmon P; Connors N
    J Ind Microbiol Biotechnol; 2001 Apr; 26(4):216-21. PubMed ID: 11464269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/Cas9-Based Genome Editing in the Filamentous Fungus
    Wei TY; Wu YJ; Xie QP; Tang JW; Yu ZT; Yang SB; Chen SX
    ACS Synth Biol; 2020 Aug; 9(8):1968-1977. PubMed ID: 32786921
    [No Abstract]   [Full Text] [Related]  

  • 23. Biosynthesis mechanism, genome mining and artificial construction of echinocandin O-sulfonation.
    Men P; Geng C; Zhang X; Zhang W; Xie L; Feng D; Du S; Wang M; Huang X; Lu X
    Metab Eng; 2022 Nov; 74():160-167. PubMed ID: 36328296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of SDS on release of intracellular pneumocandin B
    Yuan K; Huang B; Qin T; Song P; Zhang K; Ji X; Ren L; Zhang S; Huang H
    Appl Microbiol Biotechnol; 2019 Aug; 103(15):6061-6069. PubMed ID: 31161390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micafungin: a sulfated echinocandin.
    Hashimoto S
    J Antibiot (Tokyo); 2009 Jan; 62(1):27-35. PubMed ID: 19132058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel osmotic stress control strategy for improved pneumocandin B
    Song P; Huang B; Zhang S; Zhang K; Yuan K; Ji X; Ren L; Wen J; Huang H
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10729-10742. PubMed ID: 30413850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterologous Expression of Ilicicolin H Biosynthetic Gene Cluster and Production of a New Potent Antifungal Reagent, Ilicicolin J.
    Lin X; Yuan S; Chen S; Chen B; Xu H; Liu L; Li H; Gao Z
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31216742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural diversity in echinocandin biosynthesis: the impact of oxidation steps and approaches toward an evolutionary explanation.
    Hüttel W
    Z Naturforsch C J Biosci; 2017 Jan; 72(1-2):1-20. PubMed ID: 27705900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of Chemical Diversity in Echinocandin Lipopeptide Antifungal Metabolites.
    Yue Q; Chen L; Zhang X; Li K; Sun J; Liu X; An Z; Bills GF
    Eukaryot Cell; 2015 Jul; 14(7):698-718. PubMed ID: 26024901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.
    Abruzzo GK; Flattery AM; Gill CJ; Kong L; Smith JG; Krupa D; Pikounis VB; Kropp H; Bartizal K
    Antimicrob Agents Chemother; 1995 May; 39(5):1077-81. PubMed ID: 7625792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total synthesis and structure-activity relationships of new echinocandin-like antifungal cyclolipohexapeptides.
    Yao J; Liu H; Zhou T; Chen H; Miao Z; Sheng C; Zhang W
    Eur J Med Chem; 2012 Apr; 50():196-208. PubMed ID: 22348827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual fructose and osmolality affect the levels of pneumocandins B0 and C0 produced by Glarea lozoyensis.
    Connors N; Petersen L; Hughes R; Saini K; Olewinski R; Salmon P
    Appl Microbiol Biotechnol; 2000 Dec; 54(6):814-8. PubMed ID: 11152074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insight into advances for the biosynthetic progress of fermented echinocandins of antifungals.
    Jiang K; Luo P; Wang X; Lu L
    Microb Biotechnol; 2024 Jan; 17(1):e14359. PubMed ID: 37885073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antifungal activity of ASP9726, a novel echinocandin with potent Aspergillus hyphal growth inhibition.
    Morikawa H; Tomishima M; Kayakiri N; Araki T; Barrett D; Akamatsu S; Matsumoto S; Uchida S; Nakai T; Takeda S; Maki K
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1172-5. PubMed ID: 24468413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echinocandin B biosynthesis: a biosynthetic cluster from Aspergillus nidulans NRRL 8112 and reassembly of the subclusters Ecd and Hty from Aspergillus pachycristatus NRRL 11440 reveals a single coherent gene cluster.
    Hüttel W; Youssar L; Grüning BA; Günther S; Hugentobler KG
    BMC Genomics; 2016 Aug; 17():570. PubMed ID: 27502607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomics-driven discovery of a novel self-resistance mechanism in the echinocandin-producing fungus Pezicula radicicola.
    Yue Q; Li Y; Chen L; Zhang X; Liu X; An Z; Bills GF
    Environ Microbiol; 2018 Sep; 20(9):3154-3167. PubMed ID: 29528534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.
    Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C
    J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumocandin biosynthesis: involvement of a trans-selective proline hydroxylase.
    Houwaart S; Youssar L; Hüttel W
    Chembiochem; 2014 Nov; 15(16):2365-9. PubMed ID: 25270390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation, structure, and biological activity of Phaeofungin, a cyclic lipodepsipeptide from a Phaeosphaeria sp. Using the Genome-Wide Candida albicans Fitness Test.
    Singh SB; Ondeyka J; Harris G; Herath K; Zink D; Vicente F; Bills G; Collado J; Platas G; González del Val A; Martin J; Reyes F; Wang H; Kahn JN; Galuska S; Giacobbe R; Abruzzo G; Roemer T; Xu D
    J Nat Prod; 2013 Mar; 76(3):334-45. PubMed ID: 23259972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
    Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.